Chief Medical Officer of Bioxcel Therapeutics, Inc. (NASDAQ:BTAI), O’Neill Vincent, sells 25,000 shares worth $1,389,459

According to Bioxcel Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 19 07:35 PM, company Chief Medical Officer, O'Neill Vincent disclosed selling 25,000 shares at a cost of $55.58. At the time of this transaction (Feb 17), this trade was worth $1,389,459 in total. As of Feb 17, O'Neill Vincent now owns 0 shares in total worth about $0.0.

For the last few recent trades made by Bioxcel Therapeutics, Inc. (NASDAQ:BTAI) Chief Medical Officer, O'Neill Vincent, we have the following information:

Posted by George Daniels on Saturday February 20 2021, 7:33 AM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0